Insights and Analysis
AI-washing – when AI hype becomes a litigation risk
Matthew Felwick
Partner Litigation, Arbitration, and Employment
He has acted on some of the most prominent collective actions brought in England, defending clients in multi‑party, cross‑border disputes. His experience includes supporting a leading pharmaceutical company in product liability litigation and a related regulatory investigation following the withdrawal of a major product; defending a biotech company in a claim against a CRO concerning a large Phase III clinical trial; and acting for automotive manufacturers in the Pan‑NOx diesel emissions litigation. Matthew has also advised on Group Actions involving Vioxx, Blood Products, All Metal Hips, Niger Delta Oil Spills, workers’ rights issues in Africa and diesel emissions claims.
Beyond contentious matters, Matthew provides ongoing litigation risk management advice, including on coronial inquests, crisis response, product safety issues, and regulatory investigations and prosecutions. His ability to navigate scientific evidence, commercial priorities and procedural complexity makes him a trusted adviser to companies facing high‑stakes disputes.
Matthew is recognised as a Leading Partner for Product Liability:Defendant and Life Sciences & Healthcare in Legal 500, where he is described as ‘a real specialist’ who delivers ‘commercially focused advice and innovative litigation strategy'. Chambers UK ranks him Band 1 for Life Sciences:Product Liability and Band 2 for Product Liability:Defendant.